These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 22205786)
1. Molecular and microbiological characterization of Clostridium difficile isolates from single, relapse, and reinfection cases. Oka K; Osaki T; Hanawa T; Kurata S; Okazaki M; Manzoku T; Takahashi M; Tanaka M; Taguchi H; Watanabe T; Inamatsu T; Kamiya S J Clin Microbiol; 2012 Mar; 50(3):915-21. PubMed ID: 22205786 [TBL] [Abstract][Full Text] [Related]
2. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes. Sirard S; Valiquette L; Fortier LC J Clin Microbiol; 2011 Dec; 49(12):4040-6. PubMed ID: 21956985 [TBL] [Abstract][Full Text] [Related]
3. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection. Gómez S; Chaves F; Orellana MA Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842 [TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals. Nicholas A; Kim YK; Lee WK; Selasi GN; Na SH; Kwon HI; Kim YJ; Lee HS; Song KE; Shin JH; Lee JC PLoS One; 2017; 12(3):e0174716. PubMed ID: 28355266 [TBL] [Abstract][Full Text] [Related]
5. Comparison of strain typing results for Clostridium difficile isolates from North America. Tenover FC; Akerlund T; Gerding DN; Goering RV; Boström T; Jonsson AM; Wong E; Wortman AT; Persing DH J Clin Microbiol; 2011 May; 49(5):1831-7. PubMed ID: 21389155 [TBL] [Abstract][Full Text] [Related]
6. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Figueroa I; Johnson S; Sambol SP; Goldstein EJ; Citron DM; Gerding DN Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S104-9. PubMed ID: 22752857 [TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of Clostridium difficile strains from nosocomial-acquired infections. Corbellini S; Piccinelli G; De Francesco MA; Ravizzola G; Bonfanti C Folia Microbiol (Praha); 2014 Mar; 59(2):173-9. PubMed ID: 24081935 [TBL] [Abstract][Full Text] [Related]
8. Ribotyping of Clostridium difficile strains associated with nosocomial transmission and relapses in a Swedish County. Magnusson C; Wullt M; Löfgren S; Iveroth P; Akerlund T; Matussek A APMIS; 2013 Feb; 121(2):153-7. PubMed ID: 23030627 [TBL] [Abstract][Full Text] [Related]
9. The molecular characters and antibiotic resistance of Clostridioides difficile from economic animals in China. Zhang WZ; Li WG; Liu YQ; Gu WP; Zhang Q; Li H; Liu ZJ; Zhang X; Wu Y; Lu JX BMC Microbiol; 2020 Mar; 20(1):70. PubMed ID: 32228454 [TBL] [Abstract][Full Text] [Related]
10. Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013. Tickler IA; Goering RV; Whitmore JD; Lynn AN; Persing DH; Tenover FC; Antimicrob Agents Chemother; 2014 Jul; 58(7):4214-8. PubMed ID: 24752264 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities. Jon J V; Mark H W; Jane F Anaerobe; 2021 Aug; 70():102385. PubMed ID: 34048922 [TBL] [Abstract][Full Text] [Related]
13. Different antibiotic resistance and sporulation properties within multiclonal Clostridium difficile PCR ribotypes 078, 126, and 033 in a single calf farm. Zidaric V; Pardon B; Dos Vultos T; Deprez P; Brouwer MS; Roberts AP; Henriques AO; Rupnik M Appl Environ Microbiol; 2012 Dec; 78(24):8515-22. PubMed ID: 23001653 [TBL] [Abstract][Full Text] [Related]
14. The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates. Carlson PE; Walk ST; Bourgis AE; Liu MW; Kopliku F; Lo E; Young VB; Aronoff DM; Hanna PC Anaerobe; 2013 Dec; 24():109-16. PubMed ID: 23608205 [TBL] [Abstract][Full Text] [Related]
16. High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates. Tijerina-Rodríguez L; Villarreal-Treviño L; Baines SD; Morfín-Otero R; Camacho-Ortíz A; Flores-Treviño S; Maldonado-Garza H; Rodríguez-Noriega E; Garza-González E PLoS One; 2019; 14(7):e0220671. PubMed ID: 31365590 [TBL] [Abstract][Full Text] [Related]
17. Coinfection and Emergence of Rifamycin Resistance during a Recurrent Clostridium difficile Infection. Stevenson EC; Major GA; Spiller RC; Kuehne SA; Minton NP J Clin Microbiol; 2016 Nov; 54(11):2689-2694. PubMed ID: 27558181 [TBL] [Abstract][Full Text] [Related]
18. Outcome of relapsing Clostridium difficile infections do not correlate with virulence-, spore- and vegetative cell-associated phenotypes. Plaza-Garrido Á; Miranda-Cárdenas C; Castro-Córdova P; Olguín-Araneda V; Cofré-Araneda G; Hernández-Rocha C; Carman R; Ibáñez P; Fawley WN; Wilcox MH; Gil F; Calderón IL; Fuentes JA; Guzmán-Durán AM; Alvarez-Lobos M; Paredes-Sabja D Anaerobe; 2015 Dec; 36():30-8. PubMed ID: 26403333 [TBL] [Abstract][Full Text] [Related]
19. Surveillance of antimicrobial susceptibilities reveals high proportions of multidrug resistance in toxigenic Clostridium difficile strains in different areas of Poland. Lachowicz D; Pituch H; Wultańska D; Kuijper E; Obuch-Woszczatyński P Anaerobe; 2020 Apr; 62():102167. PubMed ID: 32109736 [TBL] [Abstract][Full Text] [Related]